| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90a40ed03b427343116d8d9299297632 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate |
2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b8013ced9156c7a161f294c730ee3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f0641f7d1a6574aa498cec833b9007c |
| publicationDate |
2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022023242-A1 |
| titleOfInvention |
Administration of beta-hydroxybutyrate and related compounds in humans for the treatment and/or prevention of respiratory illnesses |
| abstract |
In various implementations, beta-hydroxybutyrate may be orally administered to individuals. Administration may allow treatment and/or prevention of respiratory illnesses, in some implementations. Administration may reduce recovery times and improve outcomes in individuals with respiratory illnesses. |
| priorityDate |
2020-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |